Hong Kong stocks are fluctuating | Rongchang Bio (09995.HK) rises again by over 5%, positive results from Phase III clinical trial of Tai Etexip RC148 enters global clinical development phase.
As reported by iFinD Financial, Rongchang Biotech (09995.HK) has risen by over 5% again, with an increase of 4.28% to HK$80.6 at the time of writing, with a trading volume of HK$536 million.
Latest
2 m ago
